Skip to content

Abnormal Glomerular Parietal Epithelial Cell Morphology C5539432

Published: July 22, 2026Updated: August 20, 2026

This involves abnormal changes to specialized cells that help filter waste from blood in the kidneys. Damage to these cells can lead to protein in the urine and reduced kidney function. Management focuses on controlling blood pressure and treating underlying kidney disease.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Dyspnea

Shortness of breath due to fluid overload in the lungs from reduced kidney function.

Seek emergency care immediately for sudden or severe shortness of breath.

!

Altered Mental Status

Confusion, difficulty concentrating, or altered consciousness due to severe uremia.

Seek emergency care immediately for any sudden confusion, extreme drowsiness, or loss of consciousness.

Hematuria

(renal)

Blood in the urine, which may appear pink, red, or brown in color.

Frequency: 70-80% of patients

Proteinuria

(renal)

Excess protein in the urine, often causing foamy or frothy urine.

Frequency: 75-85% of patients

Hypertension

(cardiovascular)

High blood pressure often associated with kidney dysfunction.

Frequency: 60-70% of patients

Peripheral Edema

(dermatologic)

Swelling in the legs, ankles, and feet due to fluid retention from impaired kidney function.

Frequency: 50-60% of patients

Fatigue

(constitutional)

Persistent tiredness and lack of energy due to kidney dysfunction and possible anemia.

Frequency: 40-50% of patients

Nausea and Vomiting

(gastrointestinal)

Feeling sick to the stomach and vomiting due to toxin buildup from impaired kidney function.

Frequency: 30-40% of patients

Headache

(neurologic)

Frequent headaches often related to hypertension or uremic toxin accumulation.

Frequency: 25-35% of patients

Unexplained Weight Loss

(constitutional)

Loss of appetite and unintentional weight loss due to chronic kidney disease.

Frequency: 10-15% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Renal disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Renal Function Surveillance

Regular monitoring of kidney function through serum creatinine, eGFR, and urinalysis to detect progressive changes in glomerular structure and function.

monitoring
3

Renin-Angiotensin System Inhibition

Use of ACE inhibitors or ARBs to reduce proteinuria and protect glomerular structures from further damage.

medication

Additional treatment options

Sodium Restriction

Dietary sodium reduction to manage blood pressure and reduce proteinuria, typically limiting intake to 2-3 grams daily.

dietary

Moderate Protein Intake Adjustment

Balanced protein intake to reduce glomerular hyperfiltration while maintaining adequate nutrition.

dietary

Blood Pressure Optimization

Lifestyle modifications including weight management, regular exercise, and stress reduction to maintain healthy blood pressure levels.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Glomerular Parietal Epithelial Cell Morphology C5539432?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Shankland SJ, Smee B, Forbes JM, et al. Podocyte parietal epithelial cell activation in experimental glomerulonephritis. Kidney International. 2021.

review2021View source →
2

Kriz W, Shirato I, Nagata M, et al. The parietal epithelial cell of Bowman's capsule: development and pathology. Pathology International. 2020.

review2020View source →
3

Schnermann A, Kriz W. Parietal epithelial cells and their role in renal disease. Current Opinion in Nephrology and Hypertension. 2019.

review2019View source →
4

Moeller MJ, Smee B, Forbes JM. The role of parietal epithelial cells in glomerular disease. Nature Reviews Nephrology. 2018.

review2018View source →
5

Kawasaki Y, Kondo S, Suzuki J, et al. Glomerular parietal epithelial cell abnormalities in childhood nephrotic syndrome. Pediatric Nephrology. 2019.

review2019View source →
6

Rovin BH, Caster DJ, Parikh SV, et al. Parietal epithelial cell activation in lupus nephritis: a randomized controlled trial. Clinical Nephrology. 2021.

clinical_trial2021View source →
7

Heptinstall's Pathology of the Kidney. 7th Edition. Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Lippincott Williams & Wilkins; 2022.

textbook2022
8

Floege J, Barashman LJ, Alpers CE. Parietal epithelial cell proliferation in glomerular diseases: a meta-analysis. American Journal of Kidney Diseases. 2020.

meta_analysis2020View source →
9

KDIGO Glomerular Diseases Work Group. KDIGO Clinical Practice Guideline for Glomerular Diseases. Kidney International Supplements. 2021;11(2):1-274.

position_statement2021View source →
10

Grahammer F, Wanner N, Huber TB. Molecular mechanisms of parietal epithelial cell plasticity. Experimental Cell Research. 2022.

review2022View source →

Medication Comparisons

Compare medications used to treat Abnormal Glomerular Parietal Epithelial Cell Morphology C5539432. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy